Glooko's GestationalCare: A Digital Lifeline for Diabetes in Pregnancy

PALO ALTO, CA – September 01, 2026 – Glooko, Inc., a prominent global digital health company, has launched GestationalCare™, a specialized module for its diabetes management platform designed to transform care for one of healthcare's most time-sensitive challenges: diabetes in pregnancy. The new module aims to replace today's often-chaotic mix of paper logs, spreadsheets, and disconnected data downloads with a streamlined, unified digital workflow for clinicians and expectant mothers.

Available now to healthcare providers in the United Kingdom and slated for a U.S. launch in October 2026, GestationalCare™ supports the management of gestational diabetes (GDM), as well as Type 1 and Type 2 diabetes throughout pregnancy. The system is engineered to bring clarity and efficiency to a complex clinical pathway where timely, data-driven decisions are critical for the health of both mother and child.

The High-Stakes Challenge of Diabetes in Pregnancy

Managing diabetes during pregnancy operates on a compressed and unforgiving timeline. Glucose patterns can shift dramatically, requiring constant vigilance and rapid adjustments to treatment. For decades, the standard of care has relied on fragmented processes that put a heavy burden on both patients and providers. Clinicians in maternal-fetal medicine, endocrinology, and obstetrics often find themselves piecing together a clinical picture from disparate sources, making it difficult to spot dangerous trends or identify which patients need immediate attention.

"Diabetes in pregnancy remains one of the most time-sensitive and fragmented areas of diabetes care, and we saw a significant opportunity to address that need with our unique platform,” said Mike Alvarez, Chief Executive Officer of Glooko, in the company's announcement.

This fragmentation is more than an inconvenience; it represents a significant clinical risk. Medical bodies like the American College of Obstetricians and Gynecologists (ACOG) have long emphasized the complexities of managing glycemic control in pregnancy. Poorly managed diabetes can lead to serious complications, including preeclampsia, macrosomia (high birth weight), and neonatal hypoglycemia. Research has consistently shown that remote patient monitoring and digital health interventions can lead to better outcomes. A growing body of evidence indicates that replacing manual logs with digital tools can improve maternal glycemic control, reduce adverse pregnancy outcomes, and lower rates of C-sections.

A Unified Platform for a Fragmented Workflow

GestationalCare™ is designed to be the central hub that finally connects the dots. Integrated into Glooko's established ambulatory platform, the module provides a structured, pregnancy-specific workflow. It helps clinical teams by automatically flagging patients who may need attention based on critical signals like fasting highs, post-meal spikes, or missing data. This allows providers to move from reactive, appointment-based care to proactive population-level management.

The platform presents glucose readings against pregnancy-specific targets, organized by fasting and mealtimes, and presents it alongside patient history in a focused clinical view. This is built on Glooko’s core strength: device-agnostic data integration. The system can pull data from over 200 diabetes devices, including glucose meters, insulin pumps, and continuous glucose monitors (CGMs), centralizing information that was once siloed. Furthermore, its ability to integrate with major Electronic Health Record (EHR) systems like Epic and Oracle Health means this vital data appears directly within existing clinical workflows, a crucial feature for driving adoption and reducing clinician burnout.

“Care teams need to understand who may require attention, why and what has changed - not simply whether data were submitted,” noted Mark Clements, M.D., Ph.D., Chief Medical and Strategy Officer at Glooko. “By bringing pregnancy-specific prioritization, pattern review and between-visit engagement into the Glooko platform, GestationalCare is designed to make a complex, multidisciplinary pathway more visible and manageable for clinicians and pregnant individuals.” The module also includes features to support the critical postpartum transition, helping care teams maintain continuity after delivery for mothers who face a higher long-term risk of developing Type 2 diabetes.

Empowering Patients, Connecting Care Teams

Beyond streamlining the clinician's workflow, a key part of the GestationalCare™ strategy is empowering the patient. For pregnant individuals managing diabetes, the Glooko Mobile App becomes a powerful tool for self-management and a direct line of communication to their care team. The app facilitates device syncing, mobile logging of meals and activity, goal tracking, and access to educational content.

This digital connection replaces the often-stressful burden of manual logging and physically transporting data to appointments. Instead, patients can securely share their real-time data and context with their providers, enabling more meaningful and efficient consultations. The platform also supports secure messaging and integrated call requests, ensuring that patients and providers can remain connected between visits—a critical capability when glucose patterns can change in a matter of days.

By simplifying data sharing and improving communication, the system aims to foster a more collaborative and supportive care experience. This enhanced engagement is not just a matter of convenience; it is a clinical necessity in a high-risk pregnancy, where a patient's active participation is fundamental to achieving positive health outcomes for herself and her baby.

Market Strategy and the Digital Health Frontier

Glooko's entry into the specialized field of maternal diabetes care places it in a growing but competitive market. While companies like DarioHealth and Livongo offer broad chronic care platforms, and niche startups like Malama Health focus specifically on gestational diabetes apps, Glooko’s strategy is distinct. Rather than offering a standalone product, GestationalCare™ is an enterprise-grade module built upon a mature, trusted platform already used by thousands of clinics.

This approach gives Glooko a significant advantage in appealing to large healthcare organizations that prefer integrated, scalable solutions over a patchwork of single-purpose apps. By offering a configurable module for a specific service line, the company allows hospitals to standardize their broader diabetes management strategy while addressing the unique needs of their maternal health departments. This enterprise-ready model, backed by a subscription-based revenue structure and robust regulatory compliance (including FDA clearances and HIPAA/GDPR adherence), positions the platform as a reliable partner for health systems.

The phased rollout, starting with the UK before entering the larger U.S. market, reflects a deliberate strategy to gather real-world data and refine the offering. As healthcare continues its digital transformation, integrated, workflow-centric solutions like GestationalCare™ represent the next frontier, moving beyond simple data collection to create intelligent systems that fundamentally improve the delivery of care in high-stakes clinical areas.